Discovering and characterizing drug candidates relies upon innovative and first-class science. Charles River delivers just that, adopting a strategic collaborative approach to our partners’ discovery programs, enabling them to deliver novel therapeutics to patients in a timely and cost-effective manner.
Browse through the slide presentation to learn the benefits of outsourcing drug discovery to an end-to-end contract research organization (CRO).
Charles River offers the most comprehensive drug discovery service portfolio in the industry, supported by scientific excellence across major therapeutic areas and target classes. We’ve delivered more development candidates and patents to our sponsors than any other preclinical CRO—why travel with anyone else?